Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 7 studies | 19% ± 4% | |
endothelial cell | 6 studies | 18% ± 3% | |
alveolar macrophage | 3 studies | 23% ± 6% |
Insufficient scRNA-seq data for expression of SLFN11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 5537.99 | 653 / 653 | 98% | 18.61 | 595 / 605 |
breast | 100% | 3669.00 | 459 / 459 | 94% | 17.19 | 1055 / 1118 |
lung | 100% | 5783.66 | 578 / 578 | 94% | 22.33 | 1085 / 1155 |
ovary | 100% | 4465.42 | 180 / 180 | 91% | 12.47 | 391 / 430 |
uterus | 99% | 3222.05 | 169 / 170 | 90% | 25.84 | 413 / 459 |
esophagus | 90% | 1697.97 | 1306 / 1445 | 89% | 18.71 | 162 / 183 |
bladder | 100% | 2327.05 | 21 / 21 | 68% | 11.86 | 343 / 504 |
kidney | 89% | 1226.57 | 79 / 89 | 78% | 22.52 | 700 / 901 |
intestine | 99% | 2281.60 | 955 / 966 | 65% | 8.53 | 340 / 527 |
prostate | 98% | 2079.03 | 240 / 245 | 60% | 5.29 | 303 / 502 |
stomach | 78% | 1274.84 | 280 / 359 | 75% | 12.45 | 214 / 286 |
skin | 78% | 2583.86 | 1404 / 1809 | 69% | 13.43 | 326 / 472 |
pancreas | 46% | 458.89 | 151 / 328 | 93% | 16.04 | 166 / 178 |
adrenal gland | 95% | 1368.28 | 244 / 258 | 35% | 2.80 | 81 / 230 |
brain | 25% | 214.77 | 651 / 2642 | 83% | 10.97 | 583 / 705 |
adipose | 100% | 5370.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 5133.02 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 2341.37 | 860 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 26.44 | 44 / 45 |
blood vessel | 95% | 2499.56 | 1268 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 17.92 | 25 / 29 |
peripheral blood | 81% | 1505.25 | 748 / 929 | 0% | 0 | 0 / 0 |
muscle | 54% | 489.94 | 430 / 803 | 0% | 0 | 0 / 0 |
liver | 19% | 161.82 | 42 / 226 | 27% | 3.18 | 109 / 406 |
eye | 0% | 0 | 0 / 0 | 13% | 1.28 | 10 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006338 | Biological process | chromatin remodeling |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0051607 | Biological process | defense response to virus |
GO_0002376 | Biological process | immune system process |
GO_0006974 | Biological process | DNA damage response |
GO_0043111 | Biological process | replication fork arrest |
GO_0008156 | Biological process | negative regulation of DNA replication |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000049 | Molecular function | tRNA binding |
GO_0004386 | Molecular function | helicase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004519 | Molecular function | endonuclease activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | SLFN11 |
Protein name | Schlafen family member 11 (EC 3.6.-.-) Schlafen family member 11 |
Synonyms | |
Description | FUNCTION: Inhibitor of DNA replication that promotes cell death in response to DNA damage . Acts as a guardian of the genome by killing cells with defective replication . Persistently blocks stressed replication forks by opening chromatin across replication initiation sites at stressed replication forks, possibly leading to unwind DNA ahead of the MCM helicase and block fork progression, ultimately leading to cell death . Acts independently of ATR . Also acts as an interferon (IFN)-induced antiviral protein which acts as an inhibitor of retrovirus protein synthesis . Specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1) by acting as a specific inhibitor of the synthesis of retroviruses encoded proteins in a codon-usage-dependent manner . Binds to tRNAs and exploits the unique viral codon bias towards A/T nucleotides . The exact inhibition mechanism is unclear: may either sequester tRNAs, prevent their maturation via post-transcriptional processing or may accelerate their deacylation . Does not inhibit reverse transcription, integration or production and nuclear export of viral RNA . . |
Accessions | Q7Z7L1 ENST00000430814.5 K7ES87 ENST00000394566.5 ENST00000591682.5 ENST00000441608.6 ENST00000592108.1 ENST00000589811.5 ENST00000588579.1 K7EJJ3 ENST00000308377.8 C9JUT2 ENST00000427966.5 K7EKT7 C9JDG6 ENST00000685675.1 C9J902 K7ER38 ENST00000592122.1 K7EIM3 |